KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Interest Expenses: 2009-2024

Historic Interest Expenses for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to $16.6 million.

  • Pacira BioSciences' Interest Expenses fell 8.74% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year increase of 19.36%. This contributed to the annual value of $16.6 million for FY2024, which is 18.40% down from last year.
  • According to the latest figures from FY2024, Pacira BioSciences' Interest Expenses is $16.6 million, which was down 18.40% from $20.3 million recorded in FY2023.
  • Over the past 5 years, Pacira BioSciences' Interest Expenses peaked at $40.0 million during FY2022, and registered a low of $16.6 million during FY2024.
  • For the 3-year period, Pacira BioSciences' Interest Expenses averaged around $25.6 million, with its median value being $20.3 million (2023).
  • In the last 5 years, Pacira BioSciences' Interest Expenses climbed by 25.91% in 2022 and then tumbled by 49.20% in 2023.
  • Yearly analysis of 5 years shows Pacira BioSciences' Interest Expenses stood at $25.7 million in 2020, then increased by 23.68% to $31.8 million in 2021, then rose by 25.91% to $40.0 million in 2022, then slumped by 49.20% to $20.3 million in 2023, then fell by 18.40% to $16.6 million in 2024.